January 28, 2020
Sanofi announced that it partnered with Sebia to develop a new multiple myeloma diagnostic test that will help to mitigate the interference of isatuximab when measuring levels of monoclonal protein — a marker of disease severity — in a person’s blood. Myeloma is a cancer of plasma cells, the type of cell responsible for making...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand